 |
|
|
| |
Nonclinical Pharmacology of GS-3242, a Novel Long-Acting INSTI in Clinical Development
|
| |
| |
CROI 2026 Feb 22-25 Denver
Derek Hansen, Matthew R Hendricks, Gary Lee, Joseph Campbell, Gregg Schwarzwalder, Murali Subramanian, Joshua Dunetz, Supriya Kulkarni, Bhanu Singh, Andrea Mason, Upasana Mehra, Eric Singer, Rolando Mejorado, Yili Xu, Andrew Mulato, Ana Z Gonzalez, Tomas Cihlar and Stephen R Yant
Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
